Literature DB >> 2823937

Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region.

E Lipford1, J J Wright, W Urba, J Whang-Peng, I R Kirsch, M Raffeld, J Cossman, D L Longo, A Bakhshi, S J Korsmeyer.   

Abstract

A small (2.8-kilobase, kb) major breakpoint region localized to segment 18q21 rearranges in greater than 70% of t(14;18)(q32;q21) lymphomas. This rearrangement interrupts the Bcl-2 gene and introduces it into the Ig locus at 14q32. The rearrangement between the joining region (JH) of Ig on chromosome 14 and the 18q21 region creates a translocation-specific DNA rearrangement. We generated probes that distinguish the 14;18 juncture on the derivative (der) 14 and der (18) chromosomes, providing a molecular approach to t(14;18) identification. Approximately 60% of unselected follicular lymphomas, 20% of diffuse large cell lymphomas, and 50% of adult undifferentiated non-Burkitt lymphomas demonstrated 14;18 rearrangements within the major breakpoint region. Examination of DNA for 14;18 rearrangements resolved the identity of 14q+ chromosomes in two patient's cells that lacked an obvious reciprocal partner. Identification of the exact restriction fragments that mediate translocations complements routine cytogenetics. The detection of DNA rearrangements does not require dividing cells or the presence of an identifiable reciprocal partner and can detect clonal translocation rearrangements when the neoplastic cells are only a minority of all cells present.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823937

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Molecular diagnostic approach to non-Hodgkin's lymphoma.

Authors:  D A Arber
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

2.  The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.

Authors:  E Athan; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.

Authors:  E Athan; D R Foitl; D M Knowles
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

4.  Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.

Authors:  T W Sedlak; Z N Oltvai; E Yang; K Wang; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  The bcl-2 gene in primary B cell lymphoma of mucosa-associated lymphoid tissue (MALT).

Authors:  L Pan; T C Diss; D Cunningham; P G Isaacson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

6.  Chromosomal characteristics of malignant lymphoma.

Authors:  E W Fleischman; E L Prigogina; G W Ilynskaya; N A Probatova; L N Konstantinova; G V Kruglova; M A Volkova; D S Osmanov
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

7.  Rapid high-resolution mapping of balanced chromosomal rearrangements on tiling CGH arrays.

Authors:  Harvey A Greisman; Noah G Hoffman; Hye Son Yi
Journal:  J Mol Diagn       Date:  2011-09-09       Impact factor: 5.568

8.  Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.

Authors:  Naoto Tomita; Mami Tokunaka; Naoya Nakamura; Kengo Takeuchi; Junki Koike; Shigeki Motomura; Ko Miyamoto; Ako Kikuchi; Rie Hyo; Yoshihiro Yakushijin; Yasufumi Masaki; Soichiro Fujii; Takamasa Hayashi; Yoshiaki Ishigatsubo; Ikuo Miura
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

9.  Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease.

Authors:  M Crescenzi; M Seto; G P Herzig; P D Weiss; R C Griffith; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  The detection of specific gene rearrangements in non-Hodgkin's lymphoma using the polymerase chain reaction.

Authors:  N Corbally; L Grogan; P A Dervan; D N Carney
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.